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bstract
Cancer is one of the two leading human fatal diseases. Drug development for cancer intervention has progressed well in past decades yet existing
rugs face many limitations in applications and effectiveness and are often associated with serious of side effects, which can further deteriorate the
atients’ quality of life. Recent development of natural product based and therapeutically sound anti-cancer agents have gained popularity in the field
f functional foods, in which a few have demonstrated efficacy and minimal toxicity toward the prevention and treatment of carcinogenesis. With
ultiple active molecular components, citrus peels and derived extracts have demonstrated potent efficacious properties against various cancersue in large part to the rich content of flavonoids present in citrus peels. This review summarizes the results of currently available data regarding
he in  vivo  anti-cancer activity of citrus peel flavonoids, and identifies opportunities for subsequent human clinical trials to assess preventive and
herapeutic effects in the near future.
 2014 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. All rights reserved.
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.  Background
Medicinal use of citrus peels, such as aged tangerine peels in
outh east Asia, can be traced back to 10th century BC. However,
he systematic in-depth exploration of the biological activity of
itrus peels did not embark until the last decade, when advanced
avonoid profiles in citrus peels were established and isolation
f majority of individual flavonoids became available. Since
hen, a plethora of biological properties important to health and
iseases have been identified [1–3]. In addition to cancer preven-
ion and intervention, other biological functions of compounds
rom citrus peels investigated include inflammation inhibition
4–7], hypolipidemia [8,9], regulation of metabolic syndrome
10–13], delayed onset of Alzheimer’s disease [14,15] and more.
haracterization of the phytochemical composition of citrus
eels with modern analytical technology indicated that citrus
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ttp://dx.doi.org/10.1016/j.fshw.2014.11.001eels are an abundant source of polyhydroxyl flavonoids (PHFs)
uch as hesperidin, neohesperidin and naringin; and almost the
ole source of polymethoxyflavones (PMFs) with high con-
ent, which are mainly represented by nobiletin, tangeretin,
inesetin, 3,5,6,7,8,3′,4′-heptamethoxyflavone and 3,5,6,7,3′,4′-
examethoxyflavone [3,16,17].
Research in anti-cancer activity of citrus flavonoids has been
ajorly focused on in  vitro  experiments to elucidate action
echanisms such as anti-proliferative effects, enzyme inhibition
nd cancer cell attenuation. PMFs have demonstrated the growth
nhibition of human leukemic cell (HL-60) lines [18]. Of PMFs,
angeretin played important inhibitory roles in cancer-cell pro-
iferation and metastasis stage by inhibiting cell adhesion and
nvasion [19]; showed cell cycle arrest in G1 phase by inhibiting
yclin-dependent kinases (Cdk) and enhancing Cdk inhibitor
roteins [20]; inhibited extra cellular-signaling-regulated kinase
/2 (ERK1/2) phosphorylation and growth of human mammary
ancer cells and cytolysis by natural killer cells [21]; repressed
nduced and constitutively expressed cyclooxygenase-2 (COX-
) in human lung cancer cells [22]. In exploring the anticancer
ctivity of citrus flavonoids, another major PMF, nobiletin was
ound to have effectively inhibited the proliferation and migra-
ion of human umbilical endothelial cells of human prostate,
lsevier B.V. All rights reserved.
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kin, breast and colon carcinoma cell lines [23]; reduced AOM-
nduced cell proliferation in colonic adenocarcinoma cells [24];
uppressed the proliferation, migration and tube formation on
atrigel of human umbilical vein endothelial cells stimulated
ith endothelial cell growth supplement [25]; and attenuated
he growth of prostate cancer cells and reduced azoxymethane
AOM)-induced large bowel carcinogenesis in rats [26], to name
 few. Multiple biological pathways of anti-cancer mode of
ction by citrus flavonoids were also studied and summarized
27]. Furthermore, the study of structure activity relationship
SAR) of citrus flavonoids and cancer prevention was linked to
he structural similarities between flavonoids and 17-estradiol,
uggesting interaction of flavonoids with estrogen receptors and
lso with estrogen metabolizing enzymes, such as cytochrome
450 enzymes CYP1A1 and CYP1B1, which are over-expressed
n variety of tumor tissues [28].
Conclusions can be made from many in  vitro  studies includ-
ng those mentioned above that citrus flavonoids exert strong
nti-cancer activities. However, the beneficial effectiveness of a
rug or a nutrient can only be attested by in  vivo  efficacy stud-
es. In this review, we summarize the in  vivo  anti-cancer effect
f bioactive compounds either as single molecules or as a mix-
ure of molecules from citrus peels. The anti-cancer activity of
itrus peel flavonoids has been evaluated on several animal mod-
ls, including cancers of skin [17,29], colon [30–34], prostate
33,35], lung [36], and liver [37] among others.
.  In  vivo  anti-cancer  efﬁcacy  of  phytochemicals  in
itrus peels
.1.  Skin  cancer
In the first reported in  vivo  experiment with citrus poly-
ethoxylated flavonoids, nobiletin effectively inhibited the
roduction of hydrogen peroxide (H2O2), attributed to reduced
2− generation because of the functional relationship between
2O2 formation and O2− dismutase or other nonenzymatic reac-
ion [29]. Pretreatment with nobiletin remarkably reduced the
eight of edema, thickness of epidermis, number of infiltrated
eukocytes and H2O2 generation on TPA treated ICR mouse dor-
al skin, indicating the efficacy of nobiletin in anti-inflammation
nd anti-carcinogenesis, because the TPA induced epidermal
yperplasia and edema formation are manifest of inflammatory
rocesses leading to carcinogenesis [29].
Two-stage carcinogenesis skin model was used to character-
ze the inhibition of tumor promoting effects. The multistage
kin carcinogenesis model has initiation, promotion, and pro-
ression three distinct stages [38], which serves as a major in  vivo
odel for studying the sequential and stepwise evolution of the
ancer process by chemical and physical carcinogens. The steps
f this standard model include topical application of a single
ub-carcinogenic dose of skin carcinogen, such as DMBA that
auses irreversible DNA damage; then repeated application of
romoters such as most commonly used TPA to induce cell pro-
iferation and inflammation. This promotes the selective clonal
xpansion of initiated epidermal cells and leads to the forma-
ion of multiple squamous papillomas. Also in the same in  vivo
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xperiment, nobiletin at dosages of 0.16 and 0.32 mol/L effec-
ively inhibited the growth of mouse skin tumor initiated by
MBA and promoted by TPA in a dose-dependent manner [29].
he tumor incidence at 20 weeks was reduced by 33.5–43.3%
n nobiletin treated groups vs  in the control group. The aver-
ge number of tumors per mouse was inhibited by 61.2%
0.80 ±  0.48) at dose of 0.16 mol/L and 75.7% (0.50 ±  0.22)
t dose of 0.32 mol/L, respectively [29].
In the same skin cancer model, the topical application of
 mixed citrus peel extract (CPE) also effectively inhibited
olecular biomarkers of skin inflammation and attenuated
PA-induced skin tumor formation by reducing both the
umor incidence and tumor multiplicity of papillomas at 20
eeks, which demonstrated the efficacious anti-tumor effect of
olecules from the citrus peel extract (CPE) and the capability
f preventing inflammation-associated skin tumorigenesis [17].
he untreated positive control group of mice had 16 ±  3 papil-
omas per mouse and a 100% incidence of skin tumors at 20
eeks, whereas no tumors were observed in the negative control
roup following acetone application. However, when 100 L of
he CPE was applied to the shaven backs of mice 30 min prior
o each TPA application, the average number of papillomas per
ouse was 12 ±  4 (25% reduction compared to positive group).
n addition, the tumor incidence was found to be 100% in pos-
tive group whereas extract-treated group showed significantly
ecreased at 81%. The number of papillomas (≥5 mm in diam-
ter) per mouse was significantly decreased in the CPE treated
roup. In addition, in the positive control group in which mouse
kin tumors were initiated by DMBA and promoted by TPA
or 20 weeks, the protein expression of ornithine decarboxylase
ODC), COX-2, and VEGF (vascular endothelial growth fac-
or) was apparently increased compared to healthy skin tissue.
owever, treatment with the CPE resulted in a strong reduc-
ion of ODC, COX-2, and VEGF protein levels in skin tumors.
DC is involved in cancer proliferation and both COX-2 and
EGF contribute to angiogenesis, hence we suggest that citrus
avonoids reduced tumor size by inhibiting the tumor growth
nd angiogenesis [17].
.2.  Colon  cancer
Colorectal cancer (CRC) has high rates of mortality and
orbidity and also has increasing prevalence even with cur-
ent choices of diagnosis and medication [30]. In experimental
odels, development of CRC from normal colonic epithelium
ncludes several distinct steps, i.e.  colonic crypt hyperplasia,
ysplasia, adenoma, adenocarcinoma and distant metastasis
30,31]. The formation of aberrant crypt foci (ACF) in early
tage of the progression is widely considered a histological
iomarker of colon tumorgenesis [31]. ACF also occurs very
requently in colon cancer patients, which proposed as a puta-
ive pre-neoplastic lesion [31]. Furthermore, increased number
f incidence and multiplicity of ACFs are closely associated with
RC development [30,31]. The tumorigenesis of colon cancer
s involved in various genetic and molecular changes in cell
roliferation, inflammation, resistance to apoptosis and tumor
ngiogenesis.
1 and Human Wellness 3 (2014) 104–109
fl
m
g
c
m
1
b
w
d
c
A
g
t
e
n
e
r
p
c
m
w
l
a
s
i
i
p
s
i
o
n
A
o
c
i
I
r
n
e
o
t
w
[
f
n
i
o
T
m
m
C
i
i
A
Fig. 1. Inhibitory effects of oral administration of CPE on AOM-induced protein
levels in colorectal tissue [34]. Protein lysates from normal colonic mucosa and
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The in  vivo  study of suppressing colon cancer by citrus peel
avonoids has drew much attention in past decade. In a model of
ouse carcinogenesis, five week old mice ICR mice had a sin-
le AOM intraperitoneal injection followed by drinking water
ontaining 1% DSS (dextran sulfate sodium) for seven days. A
ajor citrus flavonoid, nobiletin (100 ppm) was fed in a diet for
7 weeks [32]. At the end of 20 weeks, the incidence and num-
er of colon tumors and serum concentration of adipocytokines
ere measured. Data has shown that the nobiletin feeding group
ramatically reduced both the incidence and the number of car-
inomas in colon tissue. The concentration of serum leptin in
OM/DSS treated mice was six times higher than that in control
roup of mice, whereas it was found no significant differences in
he concentrations of triglycerides, adiponectin and IL-6. How-
ver, the serum leptin level was reduced by 75% in the group of
obiletin ingestion mice, suggesting that the chemopreventive
ffect of nobiletin against colon tumorigenesis be through the
eduction of high level of serum leptin that was found to be a
romoter of colon carcinogenesis in mice [32].
To examine the influential factor of obesity on colorectal
ancer, the animal model of db/db mice, genetically altered
odel with the genotype of obesity and diabetes mellitus
as used [33]. The mice of strain have developed hyper-
eptinemia, hyperinsulinemia, hyperglycemia, hyperlipidemia
nd hypercholesterolemia. Obesity along with elevated levels of
erum cholesterol, triacylglycerols, glucose, insulin and leptin
s reported to be highly susceptible to colon carcinogenesis due
n part to the proliferation of cancer cells. Leptin was suggested
reviously to act as a mitogenic factor in colon carcinogene-
is of mice [32]. Hence db/db mouse model plays a useful role
n elucidating the relationship between colon tumorigenesis and
besity/diabetes [33]. Nobiletin treatment of AOM-induced pre-
eoplastic lesion in db/db mice significantly reduced the colon
CF incidence by 68%, particularly noteworthy the number
f large ACFs that are closely associated with colonic adeno-
arcinoma. Nobiletin feeding did not lower the level of leptin
n the db/db mice treated with AOM, but the serum levels of
GF-1 were dramatically decreased. It was postulated that such
eduction may lead to the suppression of proliferation in pre-
eoplastic lesions. Results from this in  vivo  study provided
vidence that citrus peel flavonoid, nobiletin is a potent inhibitor
f early stage colon carcinogenesis in obese mice via  the reduc-
ion of proliferation [33].
In addition to nobiletin, a mixture of natural citrus flavonoids
as recently examined for its in  vivo  anti-colonic cancer activity
34]. In the model of AOM-induced colonic tumorigenesis, oral
eeding of mixed citrus peel extract (CPE) decreased the total
umber of aberrant crypt foci (ACF), particularly large ACFs
n colonic tissues of mice. Both gene and protein expression
f iNOS and COX-2 were suppressed by the CPE treatment.
he in  vivo  data have revealed for the first time that CPE, the
ixed extract of citrus peels is an effective anti-tumor agent
echanistically down-regulating the protein levels of iNOS,
OX-2, ODC, VEGF, and MMP-9 (matrix metallopeptidase-9)
n colonic tissues of mice, suggesting a mechanism underlying
ts therapeutic function [34]. In the AOM model, formation of
CFs in early stage is considered to be a histological biomarker
2
nCF of each group were extracted and subjected to Western blot analysis for
NOS, COX-2, COX-1, ODC, VEGF and MMP-9 protein levels.
f colonic tumor development. Large ACFs are dysplastic, with
istological features of micro adenomas that are associated with
n increased risk for malignant progression [35]. In the efficacy
tudy of the citrus peel extract against CRC, the number of ACFs
ith CPE treated mice is remarkably lower than AOM-treated
roup of mice. Surprisingly, the number of larger ACFs was tar-
eted first and reduced by about 40% compared to that in the
OM-treated positive control group (P  < 0.05).
The development of CRC involves various genetic and
olecular changes in cell proliferation, inflammation, resis-
ance to apoptosis, angiogenesis, and metastasis. For instance,
ver expression of iNOS and COX-2 enzymes contributes to
he promotion of tumorigenesis by induction of inflamma-
ion, abnormal cell proliferation, and decreasing apoptosis.
ence, the assessment of the CPE on AOM-induced inflamma-
ory (iNOS and COX-2), proliferative (ODC) and angiogenic
VEGF and MMP-9) molecule expression in AOM-treated
ouse colon found dramatically increased expression of inflam-
atory enzymes (iNOS and COX-2) in AOM alone treated
ice. As shown in Fig. 1, CPE oral administration resulted in
 remarkable reduction of iNOS and COX-2 protein level in
ouse colon and the gene expression of both iNOS  and COX-2
enes in a dose-dependent manner compared with the AOM-
reated positive control group [34]. These results suggest that the
echanism of in  vivo  chemopreventive efficacy of CPE includes
nti-inflammation, anti-proliferation, and anti-angiogenesis in
OM-induced colonic tumorigenesis.
.3.  Prostate  cancerThe in  vivo  anti-cancer property of citrus flavonoid
obiletin was also demonstrated in chemopreventive effects
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2ig. 2. Growth of PC-3 tumor xenografts in nude mice was reduced by i.p.
reatment with 25 and 50 L of mixed CPE, respectively.
f colon and prostate cancer induced by 2-amino-1-methyl-6-
henylimidazo[4,5-b]pyridine (PhIP), which was administered
ntragastrically to six week old F344 male rats twice a week for
0 weeks [36]. In the medication group, diet containing 0.05%
obiletin was given to the rats for 50 weeks. Data has shown
hat nobiletin significantly reduced the weights of prostates
nd testes, reduced the incidence and multiplicity of adeno-
arcinomas by 50% and 64%, respectively, and furthermore,
ignificantly reduced the total number of colonic ACF [36],
hich demonstrated the in  vivo  effectiveness of citrus flavonoid
obiletin in chemoprevention of both prostate and colon car-
inogenesis [36].
Prostate cancer is one of the most prevalent male diseases
fter cardiovascular mellitus [37]. Mortality from prostate can-
er has decreased recently owing to improved early diagnosis
nd selection of more efficacious medicinal substances [38], but
t remains one of the most common malignancies with a high
ncidence, an increase in hormone-resistant types, and metasta-
is [39]. The human prostate tumor xenograft model has been
idely used in cancer therapeutic research and drug develop-
ent [40].
The mixed citrus peel extracts, CPE was also tested in
mmune-deficient mice bearing human prostate cancer cell line
C-3 tumor xenografts [41]. After the establishment of palpa-
le tumors, animals received intraperitoneal (i.p.) injections of
wo dosages of CPE (25 L and 50 L) five times per week for
3 days. Apparent inhibition of PC-3 xenograft tumor growth
as observed even at lower dose (25 L). The prostate xenograft
umor was nearly eliminated in the group treated with the higher
ose of 50 L (Fig. 2). Consistent with this observation, both
umor weight and tumor size were remarkably decreased in both
edication groups. Mice in the control group showed an aver-
ge tumor weight of 1.66 g and it was reduced by 57% in the
roup treated with the lower dose. Similarly, the average tumor
olume was five times lower in the low dose group than in the
ontrol group. Hence, tumor weight and tumor volume were
ramatically reduced by i.p.  injection of CPE in PC-3 xenograft
odel [41]. Oral dosing was also investigated in the evaluation
f therapeutic effects of this formulated CPE. Animals were
i
auman Wellness 3 (2014) 104–109 107
rally administered with 50 L or 100 L of CPE in two groups
ve times per week for 21 days. The body weight of mice in
ach group at the end of the study was not much different:
20.41 ±  2.11) g in positive control group vs  (21.22 ±  0.53) g
n 50 L of CPE-treated group vs  (21.34 ±  0.90) g in 100 L
f CPE-treated group. After 21 days of CPE oral inges-
ion, the growth of PC-3 xenograft tumors was dramatically
nhibited in both incidence and volume. The average tumor
ize in positive group was (1021.9 ±  476.2) mm3, whereas in
he CPE-treated groups, tumor size was dramatically reduced to
57.7 ±  42.0) mm3 (50 L CPE) and (69.1 ±  9.9) mm3 (100 L
PE), respectively. There was no dose-response between 50
nd100 L groups being observed because the CPE was highly
ffective even at the low dose (50 L) consumption. These
esults provided evidence that oral administration of CPE also
xerted effective efficacious activity against prostate carcino-
enesis. Therefore, in evaluating the efficacy of the mixed citrus
eel extract (CPE) against prostate cancer in a xenograft mouse
odel, we found that treatment with CPE by both i.p.  injection
nd oral administration dramatically reduced the tumor weight
nd size without any observed toxicity. This inhibitory effect
as accompanied by a down-regulation of proteins associated
ith inflammation (iNOS and COX-2), metastasis (MMP-2 and
MP-9), angiogenesis, and induction of apoptosis in prostate
umors [41].
.4.  Lung  cancer
Lung cancer remains the leading cause of cancer deaths glob-
lly. The current treatment of lung cancer is not effective as
xpected. It claims more lives than do colon, prostate, breast and
varian combined for past ten years [42]. One of the major citrus
avonoids, nobiletin has demonstrated its anti-lung cancer activ-
ty in a murine tumor model [43]. In this model, six-week-old
ale nude mice were injected with A549 cells. Treatment began
hen the tumor size reached about 75 mm3 after development
or 20 days. 3 dosages were applied in the nobiletin groups, low
ose of 100 mg/kg, medium dose of 200 mg/kg and high dose of
00 mg/kg. Cyclophosphamide (60 mg/kg) was used as control
roup and non-medicated inoculated mice as positive groups.
he results showed the inhibition percentage of tumor growth
s 51.3%, 41.3%, 29.6% and 57.6%, respectfully correspond-
ng to high (300 mg/kg), medium (200 mg/kg), low (100 mg/kg)
oses of nobiletin and cyclophosphamide (60 mg/kg). Further-
ore, there has been found no sign of toxicity judging from
ody weight of animals in nobiletin treated groups. The in  vitro
nti-cancer mechanisms of nobiletin found prior to the in  vivo
tudy included apoptosis – nobiletin induced cell cycle arrest at
2/M phase in A549 cells, inhibition of Bcl-2 protein expres-
ion, increase of Bax and p53 protein expression and elevated
rotein ratio of Bax/Bcl-2 [43].
.5.  Liver  cancerLiver cancer is one of the leading causes of death, particularly
n South East Asia. Citrus flavonoid, nobiletin has demonstrated
nti-liver cancer activity both in  vitro  and in  vivo  [44,45]. In the
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ow cytometric analysis, nobiletin blocked the cell cycle arrest at
2/M phase. The in  vivo  antitumor activity of nobiletin was per-
ormed on KM mice inoculated with H22 cells. The mice were
avage fed daily for 11 days with nobiletin at low of 125 mg/kg,
edium of 250 mg/kg and high of 500 mg/kg. Nobiletin signifi-
antly inhibited tumor growth at high dose group and it was also
ound to have down-regulated the Bcl-2 and COX-2 expression
nd up-regulated the expression of Bax  and caspase-3 in HCC
ell line (SMMC-7721 cells) in Western blot [45]. The ratio
f Bcl-2/Bax was significantly reduced at dosages of 250 and
00 mg/kg. Nobiletin also effectively suppressed the expression
f COX-2 [45].
.  Citrus  ﬂavonoids  and  their  biological  activity
Citrus and citrus peels contain common flavonoids, such
s hesperidin, naringin, neohesperidin, narirutin, eriocitrin,
idymin and rutin among others [27,46,47]. A number of
tudies have demonstrated the biological properties of these
itrus flavonoids including anti-carcinogenic, anti-oxidant and
nti-inflammatory properties that promote and benefit human
ealth [46–49]. In addition to citrus flavonoids, citrus peels
re also the sole and rich source of polymethoxylated
avonoids, which were found to exert many biological prop-
rties, particularly anti-cancer and anti-inflammatory activity
1,4,5,7]. Recent studies have also demonstrated potent anti-
arcinogenic and anti-inflammatory efficacy of 5-demethylated
olymethoxyflavones in single molecules [5,50,51] or in mul-
iple 5-demethylated polymethoxyflavones [52]. The natural
ontent of 5-demethylated polymethoxyflavones in citrus peels
s low in percentage, but it has been confirmed that they have
ore potent biological activity than their non-demethylated
ounterparts, such as anticancer activity [50–52].
In essence, there are three subclasses of citrus flavonoids
xiting abundantly in citrus peels, namely, polyhydrox-
flavonoids, polymethoxyflavonoids and mixed substituted
avonoids with both hydroxyl and methoxyl groups, particu-
arly 5-demethylated polymethoxyflavnoids. These flavonoids
ave demonstrated effective anti-cancer property both in  vitro
nd in  vivo, either in a form of individual compounds or in
 mixture of citrus flavonoids. The anti-cancer study of these
avonoids has progressed well in recent years owing albeit in
he initial steps to the modern chemical analysis and isolation
nd the biological activity testing. However, with the exception
f nobiletin, the relationships between each individual flavonoid
n citrus peels and its bioactivity such as anti-carcinogenesis
emain untouched to some extent. Relationships among the nat-
rally proportioned flavonoids in citrus peels and their biological
ctivities are even more complex and unexplored.
.  Conclusion
In summary, the in  vivo  studies provide compelling evidence
hat flavonoids from citrus peels, such as nobiletin and citrus
eel extract (CPE) demonstrated potent anti-tumor activities
n cancers of skin, colon, prostate, lung and liver. The ther-
peutic mechanism may include inhibition of inflammation,uman Wellness 3 (2014) 104–109
roliferation, angiogenesis, and induction of apoptosis. A char-
cteristic and unusual feature of flavonoids from citrus peels is
heir high concentration of a diverse assortment of polyhydrox-
lated flavonoids, polymethoxyflavones, and other flavonoids.
obiletin, a representative of citrus polymethoxyflavones,
xpressed potent efficacious activity against carcinogenesis.
n view of other studies examining the impact of individual
avonoids such as polyhydroxylated flavonoids (PHFs) or poly-
ethoxyflavones (PMFs) and related flavonoids [1], it is possible
hat the biological properties of mixed flavonoids from citrus
eels summarized above are due to an additive or synergistic
nteraction of the complex mixture of phytochemicals, which
ay provide enhanced anti-cancer efficacy. The detailed mech-
nisms by which these flavonoids in citrus peel exert optimal
enefits remain to be further elucidated. However, the evidence
resented in this review illustrates that citrus flavonoids could
rove to be an effective anti-cancer agent, especially against
kin, colon, prostate, lung and liver cancer and encourage future
esearch to evaluate its efficacy in human clinical trials.
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